Advertisement
Screener

3M CO (MMM) Overview

3M CO (MMM) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 1.78; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 1.23; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 1.55; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 1.34; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$134.14$144.66$156.01$168.25$181.44$195.682025-11-062026-11-06$67.99$86.67$110.49$140.85$179.56$228.902021-11-082026-11-06$67.99$89.29$117.26$153.99$202.23$265.572016-11-072026-11-06$33.22$53.03$84.66$135.14$215.74$344.392006-11-062026-11-06$3.55$11.15$35.00$109.85$344.75$1,082.031970-01-022026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$185.24
Previous close
$168.49
Change
$16.75
Change (%)
9.94%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

MMM
+6.72%
S&P 500
(m)

1 year

MMM
+11.37%
S&P 500
(m)

3 years

MMM
+133.74%
S&P 500
(m)

5 years

MMM
+32.73%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 1.78

1.151.421.691.952.2231 Mar 2025: estimate (m); actual 2.0431 Mar 2025(m)30 Jun 2025: estimate (m); actual 1.3430 Jun 2025(m)30 Sept 2025: estimate (m); actual 1.5530 Sept 2025(m)31 Mar 2026: estimate (m); actual 1.2331 Mar 2026(m)30 Jun 2026: estimate (m); actual 1.7830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)1.78(m)(m)
1 Jan 202631 Mar 2026(m)1.23(m)(m)
1 Jul 202530 Sept 2025(m)1.55(m)(m)
1 Apr 202530 Jun 2025(m)1.34(m)(m)
1 Jan 202531 Mar 2025(m)2.04(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 6.00

-12.71-6.94-1.184.5910.3631 Dec 2021: estimate (m); actual 10.1231 Dec 2021(m)31 Dec 2022: estimate (m); actual 10.1831 Dec 2022(m)31 Dec 2023: estimate (m); actual -12.6331 Dec 2023(m)31 Dec 2024: estimate (m); actual 7.5531 Dec 2024(m)31 Dec 2025: estimate (m); actual 6.0031 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)6.00(m)(m)
1 Jan 202431 Dec 2024(m)7.55(m)(m)
1 Jan 202331 Dec 2023(m)-12.63(m)(m)
1 Jan 202231 Dec 2022(m)10.18(m)(m)
1 Jan 202131 Dec 2021(m)10.12(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 6.50B ■ Earnings 0.93B — Profit margin 14.35%

-0.78B8.4%1.91B10.7%4.61B13.0%7.30B15.4%30 Sept 2025: revenue 6.52B; earnings 0.83B; profit margin 12.80%30 Sept 202531 Dec 2025: revenue 6.13B*; earnings 0.58B*; profit margin 9.41%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 6.03B; earnings 0.65B; profit margin 10.83%31 Mar 202630 Jun 2026: revenue 6.50B; earnings 0.93B; profit margin 14.35%30 Jun 2026

31 Dec 2025 ■ Revenue 24.95B ■ Earnings 3.25B — Profit margin 13.03%

-10.97B-29.4%2.73B-11.9%16.44B5.6%30.14B23.1%31 Dec 2022: revenue 26.16B; earnings 5.78B; profit margin 22.08%31 Dec 202231 Dec 2023: revenue 24.61B; earnings -7.00B; profit margin -28.42%31 Dec 202331 Dec 2024: revenue 24.57B; earnings 4.17B; profit margin 16.98%31 Dec 202431 Dec 2025: revenue 24.95B; earnings 3.25B; profit margin 13.03%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$185.24(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$185.24High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning MMM

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
96.16K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.97M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-0.48%*
Total return · month
-3.36%*
Total return · quarter
4.19%*
Total return · half year
18.92%*
Total return · year to date
6.72%*
Total return · 1 year
11.37%*
Total return · 3 years
133.74%*
Total return · 5 years
32.73%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

3M CO Overview

View more →

(m)

(m)

SEC CIK
66740
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
3M CENTER, BLDG. 220-9E-02, ST PAUL, Minnesota, 55144-1000, United States
Fiscal year end
1231
Phone
6517331110

Similar stocks

Stock NameCountryMarket CapPE Ratio
STRYKER CORP (SYK)United States$103.511B32.39
BOSTON SCIENTIFIC CORP (BSX)United States$64.781B17.29
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12